查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018498

腦部PET-MRI系統市場：依產品類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

Brain PET-MRI Systems Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腦部 PET-MRI 系統市值將達到 46.9 億美元，到 2026 年將成長至 52.5 億美元，到 2032 年將達到 113 億美元，年複合成長率為 13.38%。

主要市場統計數據
基準年 2025 46.9億美元
預計年份：2026年 52.5億美元
預測年份 2032 113億美元
複合年成長率 (%) 13.38%

這本權威的入門書籍說明了混合 PET-MRI 腦系統如何改變神經病學和腫瘤學的診斷準確性、研究發現和臨床決策過程。

腦部PET-MRI系統融合了功能性影像和結構影像，使臨床醫師和研究人員能夠以更高的診斷信心應對複雜的神經系統疾病和腫瘤學挑戰。透過將正子斷層掃描（PET）的分子級靈敏度與磁振造影（MRI）卓越的軟組織對比度相結合，這些混合平台能夠提高病灶檢出率，闡明腫瘤的生物學特徵，並提供多維度資訊以輔助治療方案的發展。隨著臨床路徑的不斷發展，混合成像技術透過實現更早期的病灶檢測、更好地區分腫瘤復發和治療反應以及更準確地對患者進行分層以進行標靶治療，日益支持精準醫療的發展。

對加速混合影像技術應用和重新定義腦部診斷護理路徑的關鍵技術和臨床變革進行了引人入勝的概述。

腦部PET-MRI系統正經歷一場變革，這主要得益於檢測器技術、軟體整合以及不斷變化的臨床需求的進步。飛行時間（TOF）影像技術、先進的MRI序列和混合重建演算法提高了訊號雜訊比（SNR）和定量可靠性，即使在微病灶和異質性組織環境中，也能實現更可靠的影像解讀。同時，基於人工智慧和放射組學的軟體生態系統簡化了影像分析工作流程，實現了病灶的自動分割，並提取了高價值的影像生物標記物，從而支援預後和預測建模。這些軟硬體結合的進步正在拓展腦部PET-MRI的效用，使其從專業研究領域擴展到更廣泛的臨床應用。

對 2025 年美國關稅調整將如何影響混合腦影像系統的採購決策、供應鏈韌性和資本配置進行詳細評估。

2025年實施的最新關稅措施進一步增加了先進腦部PET-MRI系統的採購和部署複雜性。這些政策變化影響了關鍵子系統的進口成本，例如精密檢測器、梯度線圈和電子元件，這些元件通常透過國際供應鏈採購。實際上，採購團隊面臨著更長的前置作業時間和更高的採購價格，這影響了資本投資週期和升級計畫。因此，一些機構推遲了非緊急採購，而另一些機構則在探索替代籌資策略以緩解短期預算壓力。

一項重點細分分析，解釋了產品架構、成像技術選擇、臨床應用和最終用戶概況如何決定部署和部署策略。

產品配置在很大程度上決定了買家的偏好，整合式系統和串聯式系統在工作流程和效能方面各有優劣。整合式系統對需要同時進行PET和MRI掃描且受益於整合式機架設計的機構極具吸引力。在整合式產品系列中，高場和低場實現方式的差異進一步影響了它們的臨床定位；高場系統優先考慮空間解析度和先進的光譜分析，而低場平台則強調成本效益和易於安裝。相較之下，串聯式系統提供順序工作流程，使其更適合現有設施的改造或分階段投資，使醫療機構能夠隨著時間的推移擴展其混合成像能力。

一項全面的區域分析重點闡述了法律規範、資金籌措模式和臨床生態系統如何在全球範圍內造成不同的採用趨勢。

區域環境對腦部PET-MRI系統的優先部署與應用有顯著影響。監管環境、醫療保健資金籌措模式和研究集中度的差異決定了系統的部署時間表。在美洲，這些系統往往集中在先進的大學醫院和三級醫療機構。這些機構需要在整合的研究和臨床計畫中運用高性能影像技術和先進的示蹤劑開發。因此，其部署策略專注於強大的處理能力、先進的定量分析以及與製藥公司和神經病學研究團隊的合作。相較之下，歐洲、中東和非洲（EMEA）地區的環境則較為複雜，監管協調、多樣化的報銷途徑以及基礎設施成熟度的差異等因素，使得高度靈活的資金籌措和服務模式成為必要。在這些地區，供應商通常會尋求區域夥伴關係和本地化的培訓項目，以加速臨床應用並確保投資回報。

這項富有洞察力的公司層面分析說明了產品創新、服務模式和策略夥伴關係關係如何塑造混合腦成像領域的競爭格局和臨床應用。

領先的供應商不斷透過整合平台效能、整合服務交付以及與臨床和研究機構的策略合作來提升自身競爭力。產品藍圖強調提高檢測器靈敏度、軟體主導的工作流程自動化以及模組化配置，從而降低安裝複雜性並支援分階段升級。隨著醫療機構要求確保新系統能夠帶來可衡量的診斷和操作效益，那些將強大的臨床證據生成與針對神經放射科醫生和核醫學專家的專項培訓計劃相結合的供應商正在獲得更高的臨床滲透率。

為醫療設備製造商、醫療保健系統和投資者提供可操作且優先的策略指導，以加速混合成像技術的應用，並確保臨床和商業性回報。

供應商應優先考慮產品設計的模組化，使醫療機構能夠部署基準混合功能，並隨著臨床需求的成長擴展到更高階的配置。投資於飛行時間 (ToF) 性能、先進的重配置軟體以及與人工智慧分析的原生整合，將滿足臨床醫生對更佳病灶檢測能力和更有效率工作流程的需求。同時，製造商必須透過擴展區域服務網路和提供靈活的資金籌措模式，降低用戶採用產品的門檻，並減少與購買相關的感知風險。這些戰術性調整將縮短銷售週期，並促進更廣泛的臨床應用。

本文檔說明了一種清晰且可重複的調查方法，結合了第一手訪談、第二手資料和檢驗，以產生可靠且可操作的見解。

本分析整合了從醫療保健高管、影像科主任、臨床研究人員和技術專家訪談中獲得的第一手資料，並結合了同行評審文獻、監管文件和產品文件等二手資料。透過交叉比對技術規範、臨床試驗結果和服務模式資訊披露信息，對有關性能、處理能力和操作要求的說法進行數據三角檢驗。在條件允許的情況下，基於多中心研究和已發表方案的實證證據，評估了相對臨床價值和推廣應用障礙。

簡要概述了將混合腦造影技術的進步轉化為常規臨床效益的關鍵促進因素、策略重點和實際步驟。

腦部PET-MRI系統融合了臨床需求和技術可能性，具有提升診斷準確性和支持科研創新的獨特優勢。隨著供應商和醫療機構在高性能成像、靈活資金籌措和完善的服務體係等解決方案上達成共識，腦部PET-MRI系統的應用將持續加速。臨床領導者和多學科團隊將繼續發揮關鍵作用，展現其價值，並將混合成像技術整合到臨床流程中，尤其是在神經病學和神經腫瘤學領域，分子數據和結構數據具有協同效應。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：腦部PET-MRI系統市場：依產品類型分類

  • 整合系統
    • 高磁場系統
    • 低磁場系統
  • 串聯系統

第9章：腦部PET-MRI系統市場：依技術分類

  • 傳統的
  • 飛行時間法

第10章：腦部PET-MRI系統市場：依應用領域分類

  • 循環系統
  • 神經病學
  • 腫瘤學
    • 腦轉移癌
    • 原發性腦腫瘤

第11章：腦部PET-MRI系統市場：依最終使用者分類

  • 診斷中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究機構

第12章：腦部PET-MRI系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：腦部PET-MRI系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：腦部PET-MRI系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國腦部PET-MRI系統市場

第16章：中國腦部PET-MRI系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced Accelerator Applications SA
  • Aspect Imaging Ltd.
  • Bruker Corporation
  • Carestream Health, Inc.
  • Cerveau Technologies, Inc.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hyperfine Research, Inc.
  • Inviscan SAS
  • Koninklijke Philips NV
  • Mediso Ltd.
  • Mindray Medical International Limited
  • MR Solutions Ltd.
  • Neurologix, Inc.
  • Neusoft Medical Systems Co., Ltd.
  • Positron Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Sofie Biosciences, Inc.
  • Spectrum Dynamics Medical
  • Synaptive Medical, Inc.
  • Time Medical Systems
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-A339DAEFA416

The Brain PET-MRI Systems Market was valued at USD 4.69 billion in 2025 and is projected to grow to USD 5.25 billion in 2026, with a CAGR of 13.38%, reaching USD 11.30 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.69 billion
Estimated Year [2026] USD 5.25 billion
Forecast Year [2032] USD 11.30 billion
CAGR (%) 13.38%

An authoritative introduction explaining how hybrid PET-MRI brain systems reshape diagnostic precision, research discovery, and clinical decision pathways in neurology and oncology

Brain PET-MRI systems represent a convergence of functional and structural imaging that enables clinicians and researchers to address complex neurological and oncological challenges with greater diagnostic confidence. By combining positron emission tomography's molecular sensitivity with magnetic resonance imaging's superior soft tissue contrast, these hybrid platforms offer multidimensional insights that enhance lesion detection, characterize tumor biology, and inform therapy planning. As clinical pathways evolve, hybrid imaging increasingly supports precision medicine approaches by enabling earlier detection of pathology, improved differentiation between tumor recurrence and treatment effects, and more informed patient stratification for targeted therapies.

From a research perspective, the integrated modality accelerates translational studies by facilitating simultaneous acquisition of complementary biomarkers, reducing registration errors, and enabling longitudinal assessments that link molecular changes with structural and functional outcomes. As a result, academic centers and specialized hospitals are leveraging brain PET-MRI to deepen understanding of neurodegenerative diseases, map metabolic alterations in epilepsy, and refine radiotracer development. Consequently, adoption decisions now hinge not only on image quality and throughput but also on interoperability with AI-driven analytics, radiomics pipelines, and multimodal data management systems, which collectively drive higher clinical value and expanded use cases.

A compelling overview of the major technological and clinical shifts that are accelerating hybrid imaging adoption and redefining care pathways in brain diagnostics

The landscape for brain PET-MRI systems is undergoing transformative shifts driven by improvements in detector technology, software integration, and clinical demand patterns. Time-of-flight capabilities, advanced MRI sequences, and hybrid reconstruction algorithms have improved signal-to-noise ratios and quantitative reliability, enabling more confident interpretations in small lesions and heterogeneous tissue environments. Concurrently, software ecosystems built around artificial intelligence and radiomics are streamlining image analysis workflows, enabling automated lesion segmentation, and extracting high-value imaging biomarkers that support prognostic and predictive modeling. This combination of hardware and software progress is expanding the utility of brain PET-MRI from specialized research settings into broader clinical practice.

Additionally, operational models are evolving as providers prioritize value-based care and cost-effective utilization. Imaging departments seek systems that balance image quality with throughput, serviceability, and lifecycle costs. Vendors are responding by offering modular platforms, flexible service contracts, and financing solutions that lower the barrier to adoption. At the same time, the regulatory and reimbursement environment is adapting to recognize the clinical benefits of hybrid imaging, encouraging trials that demonstrate patient outcomes and cost offsets. As a result, hospitals and research centers are re-evaluating capital allocation strategies, and new collaborative models between device manufacturers, academic institutions, and clinical networks are emerging to accelerate adoption and clinical validation.

A detailed assessment of how 2025 United States tariff adjustments are influencing procurement decisions, supply chain resilience, and capital deployment for hybrid brain imaging systems

Recent tariff measures enacted in 2025 have introduced an additional layer of complexity into the procurement and deployment of advanced brain PET-MRI systems. These policy changes have affected import costs for key subsystems, including precision detectors, gradient coils, and electronic components, which are often sourced through international supply chains. In practice, procurement teams have encountered longer lead times and elevated purchase prices that influence capital expenditure cycles and refresh plans. Consequently, some institutions have deferred nonurgent purchases while others have sought alternative procurement strategies to mitigate short-term budgetary pressure.

Beyond direct cost implications, tariffs have catalyzed strategic responses across the value chain. Vendors have accelerated localization of manufacturing for high-cost components, renegotiated supplier contracts, and prioritized investments in regional service infrastructure to reduce exposure to cross-border tariffs. Hospitals and research centers are increasingly demanding transparent total-cost-of-ownership models and warranties that reflect tariff-induced volatility. Meanwhile, finance teams are revisiting leasing and managed-service alternatives to preserve clinical capacity without absorbing the full upfront tariff impact. Taken together, these adjustments are reshaping purchase decision criteria and driving a reevaluation of global sourcing strategies for advanced imaging technologies.

Focused segmentation analysis explaining how product architecture, imaging technology choices, clinical applications, and end-user profiles determine adoption and deployment strategies

Product configuration explains a significant portion of buyer preference, with integrated systems and tandem systems offering distinct trade-offs in workflow and performance. Integrated systems appeal to centers that require simultaneous PET and MRI acquisition and benefit from consolidated gantry design; within integrated offerings, distinctions between high field and low field implementations further shape clinical positioning, with high field systems prioritizing spatial resolution and advanced spectroscopy while low field platforms emphasize cost-effectiveness and ease of siting. Tandem systems, by contrast, provide sequential workflows and can be advantageous where retrofitting or staged investment is preferred, enabling institutions to scale hybrid capability over time.

Technology choice also drives clinical suitability, particularly when considering conventional PET approaches versus time-of-flight-enabled systems. Time-of-flight enhances sensitivity and quantitation, improving detectability for small lesions and aiding in complex brain imaging scenarios. Application-driven segmentation clarifies use case priorities: cardiology, neurology, and oncology each demand tailored imaging protocols and tracer portfolios, and oncology use cases subdivide further into metastatic brain cancer and primary brain tumors where diagnostic objectives and therapeutic monitoring differ substantially. Finally, end-user characteristics influence purchasing and deployment, with diagnostic centers, hospitals, and research institutions exhibiting distinct operational models and volume expectations; hospitals themselves bifurcate into private and public establishments, reflecting divergent capital approval processes, reimbursement frameworks, and service delivery imperatives. When combined, these segmentation lenses inform product roadmaps, service models, and clinical validation strategies for suppliers and providers alike.

Comprehensive regional intelligence highlighting how regulatory frameworks, funding models, and clinical ecosystems drive differentiated adoption across global territories

Regional context materially alters how brain PET-MRI systems are prioritized and utilized, with differences in regulatory landscapes, healthcare funding models, and research concentration shaping adoption timelines. In the Americas, systems tend to be concentrated in advanced academic medical centers and tertiary hospitals where integrated research and clinical programs expect high-performance imaging and sophisticated tracer development. As a result, deployment strategies emphasize throughput, advanced quantitation, and partnerships with pharmaceutical and neurology research groups. By contrast, Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory harmonization, variable reimbursement pathways, and diverse infrastructure maturity require adaptable financing and service models. Here, vendors often pursue regional partnerships and localized training programs to accelerate clinical acceptance and ensure return on investment.

In the Asia-Pacific region, strong investment in healthcare infrastructure and expanding research networks are accelerating uptake, yet procurement decisions reflect a balance between cost sensitivity and aspirations for leading-edge capability. Emerging centers prioritize modular solutions that can scale from basic hybrid functionality toward fully integrated high-field performance as clinical demand grows. Across all regions, interoperability with health IT systems, availability of trained technologists and radiochemists, and the presence of clinical champions remain decisive factors in successful deployments. Consequently, manufacturers and providers must tailor commercial strategies, service footprints, and clinical support to align with the distinct operational realities of each region.

Insightful company-level analysis describing how product innovation, service models, and strategic partnerships are shaping competition and clinical adoption in hybrid brain imaging

Leading suppliers continue to differentiate through a combination of platform performance, integrated service offerings, and strategic partnerships with clinical and research institutions. Product roadmaps emphasize improvements in detector sensitivity, software-driven workflow automation, and modular configurations that reduce installation complexity and support incremental upgrades. Vendors that pair robust clinical evidence generation with targeted training programs for neuroradiologists and nuclear medicine specialists achieve greater clinical traction, as providers seek assurance that new systems will translate into measurable diagnostic and operational benefits.

Service and financing models remain powerful competitive levers. Companies that provide outcome-oriented service agreements, remote monitoring, and predictive maintenance reduce downtime and lower total operational risk for hospital systems. Meanwhile, strategic collaborations with academic centers and tracer manufacturers accelerate clinical validation and broaden the range of supported applications. In this environment, smaller innovators focused on niche capabilities such as advanced reconstruction algorithms or compact low-field integrated designs can capture specific segments by offering complementary solutions that integrate with larger platform providers. Overall, the competitive landscape rewards firms that combine technological differentiation with pragmatic support solutions and evidence-driven commercialization.

Actionable and prioritized strategic guidance that enables device makers, healthcare systems, and investors to accelerate adoption and secure clinical and commercial returns from hybrid imaging

Vendors should prioritize modularity in product design, enabling institutions to adopt baseline hybrid capability and scale to more advanced configurations as clinical demand grows. Investing in time-of-flight performance, advanced reconstruction software, and native integration with AI analytics will address clinician needs for improved lesion detectability and efficient workflows. Simultaneously, manufacturers must expand regional service networks and offer flexible financing models to mitigate procurement hurdles and reduce perceived acquisition risk. These tactical changes will shorten sales cycles and support broader clinical deployment.

Healthcare providers and research institutions should develop multidisciplinary implementation plans that align neuroradiology, nuclear medicine, and oncology stakeholders early in the procurement process. Establishing local tracer access, standardized imaging protocols, and outcome-tracking mechanisms will ensure that new systems deliver measurable clinical impact. Investors and system purchasers should stress-test vendor supply chains and contract terms against geopolitical and tariff-related risks, while endorsing managed-service approaches that distribute risk and preserve capital. Across stakeholders, prioritizing evidence generation through prospective clinical studies and real-world registries will be crucial to securing favorable reimbursement and driving long-term utilization.

A clear and reproducible research methodology detailing how primary interviews, secondary evidence, and triangulation combine to produce reliable and actionable insights

This analysis synthesizes primary insights from interviews with healthcare executives, imaging directors, clinical investigators, and technical experts, coupled with secondary research using peer-reviewed literature, regulatory filings, and product documentation. Data triangulation occurred by cross-referencing technical specifications with clinical trial outcomes and service model disclosures to validate claims about performance, throughput, and operational requirements. Wherever possible, empirical evidence from multi-center studies and published protocols informed assessments of relative clinical value and adoption hurdles.

The methodology also incorporates qualitative assessment of procurement processes, reimbursement trends, and supply chain resilience derived from stakeholder consultations. Limitations are acknowledged: proprietary vendor data and emerging technologies with limited clinical deployments required careful extrapolation and conservative interpretation. To mitigate bias, expert perspectives were sourced from diverse geographies and institutional types, and findings were reviewed for internal consistency and alignment with documented clinical practice guidelines. This transparent approach aims to deliver actionable intelligence while clearly communicating the assumptions and evidence underpinning the conclusions.

A concise concluding synthesis highlighting the critical enablers, strategic priorities, and practical steps required to translate hybrid brain imaging advances into routine clinical benefit

Brain PET-MRI systems stand at the intersection of clinical need and technological possibility, offering unique capabilities to improve diagnostic precision and support research innovation. Adoption will continue to accelerate where vendors and providers align on solutions that combine high-performance imaging, adaptable financing, and strong service ecosystems. Clinical champions and multidisciplinary teams will remain pivotal in demonstrating value and embedding hybrid imaging into care pathways, particularly in neurology and neuro-oncology applications where molecular and structural data synergize.

Looking ahead, success will depend on pragmatic strategies that address supply chain fragility, regulatory complexity, and workforce readiness. Stakeholders who invest in evidence generation, regional service capacity, and interoperable software ecosystems will be best positioned to convert technological advances into routine clinical benefit. As institutions refine their priorities, those that adopt flexible procurement models and that partner strategically with technology providers will achieve a balance between innovation and operational sustainability, enabling broader access to the clinical and research advantages of hybrid brain imaging.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain PET-MRI Systems Market, by Product Type

  • 8.1. Integrated Systems
    • 8.1.1. High Field Systems
    • 8.1.2. Low Field Systems
  • 8.2. Tandem Systems

9. Brain PET-MRI Systems Market, by Technology

  • 9.1. Conventional
  • 9.2. Time Of Flight

10. Brain PET-MRI Systems Market, by Application

  • 10.1. Cardiology
  • 10.2. Neurology
  • 10.3. Oncology
    • 10.3.1. Metastatic Brain Cancer
    • 10.3.2. Primary Brain Tumors

11. Brain PET-MRI Systems Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals
  • 11.3. Research Institutions

12. Brain PET-MRI Systems Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brain PET-MRI Systems Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brain PET-MRI Systems Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Brain PET-MRI Systems Market

16. China Brain PET-MRI Systems Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced Accelerator Applications S.A.
  • 17.6. Aspect Imaging Ltd.
  • 17.7. Bruker Corporation
  • 17.8. Carestream Health, Inc.
  • 17.9. Cerveau Technologies, Inc.
  • 17.10. Fujifilm Holdings Corporation
  • 17.11. GE HealthCare Technologies Inc.
  • 17.12. Hitachi, Ltd.
  • 17.13. Hyperfine Research, Inc.
  • 17.14. Inviscan SAS
  • 17.15. Koninklijke Philips N.V.
  • 17.16. Mediso Ltd.
  • 17.17. Mindray Medical International Limited
  • 17.18. MR Solutions Ltd.
  • 17.19. Neurologix, Inc.
  • 17.20. Neusoft Medical Systems Co., Ltd.
  • 17.21. Positron Corporation
  • 17.22. Shimadzu Corporation
  • 17.23. Siemens Healthineers AG
  • 17.24. Sofie Biosciences, Inc.
  • 17.25. Spectrum Dynamics Medical
  • 17.26. Synaptive Medical, Inc.
  • 17.27. Time Medical Systems
  • 17.28. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRAIN PET-MRI SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 134. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)